Chronic and Infectious Diseases
The following is a list of externally-funded projects being conducted by FHS researchers under this thematic area. A number of the projects are cross-cutting and may also be listed under other themes of strategic importance to this faculty. For details and abstracts of each projects, please click on the project title link.
- Identification, characterization, and validation of genetic mutations incurred during in vitro attenuation of Marek’s disease virus
- Marek's Disease - Replication dynamics, pathogenesis, and vaccine effect
- Barriers to engaging young people in HIV vaccine trials in a priority setting
- Vaccines that replicate neutralization-competent structures within the membrane proximal external region of HIV-1 gp41
- Canadian HIV Women and Reproductive Health Cohort Study
- Using a systems analytic approach to lviing (SynAl) with Chronic Diseases
- How cells interpret DNA methylation to regulate gene transcription
- A prospective investigation of trends and determinants of pregnancy among HIV-positive individuals accessing anti-retroviral treatments in Mbarrara, Uganda: A UARTO affiliated study
- Effect of HAART expansion on community levels of HIV viral load and HIV risk behaviours among MSM in British Columbia
- HIV/AIDS prevention, care and support in Karnataka, India
- HIV adaptation to immune selection pressures:historic trends and future implications
- Building capacity to respond to HIV/AIDS in China
- Regulation of amyloid beta metabolism
- Impact of HLA-driven immune escape on HIV replicative capacity
- Sugar-coated designer immunogens to elicit HIV-1 neutralizing antibodies
- Immunogen design to elicit broadly neutralizing antibodies to influenza
- Exploring antibody recognition of the V3 region on HIV-1 to guide vaccine design
- Adherence to HAART in HIV Populations: a meta analysis
- CIHR Applied Public Health Chair - Infectious diseases, substance use, marginalized populations and public health
- Effect of immune-mediated alterations on the replication capacity of recombinant viruses expressing the Pol gene from HIV-1 Elite Controllers
